Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

A rare scalp tumor was removed from a 49-year-old woman, with a good outlook if benign but needing careful monitoring if malignant.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Patients with one autoimmune disease should be checked for other autoimmune disorders.

NK cells play a role in skin diseases like eczema and psoriasis.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

A patient with "strawberry gingivitis" improved after correct treatment for Granulomatosis with polyangiitis, highlighting the need for early diagnosis.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Nilotinib can cause keratosis pilaris, a skin condition.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

Consider Castleman's disease in similar cases; histology and steroids help diagnose and manage it.

The patient had a severe allergic reaction to gold treatment.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Erosive pustular dermatosis in elderly people may be linked to aging immune systems and skin damage.

An HIV patient with IRIS had rare syphilis symptoms affecting skin, eyes, and nerves.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.